Clinical Trials in Czech Republic
Active recruiting clinical trials with sites in Czech Republic. Select a condition below to see detailed trial listings.
Czech Republic currently has 61 clinical trials with at least one registered site in the country, of which 61 are actively recruiting participants. The most studied conditions at Czech Republic sites are Atrial Fibrillation, Obesity, Parkinson Disease, reflecting where local investigators and sponsors are concentrating enrolment.
Studies are led by sponsors including Charles University, Czech Republic, University Hospital Ostrava, Pfizer. By stage, active Czech Republic trials break down as Phase 1 (4), Phase 2 (12), Phase 3 (13), Phase 4 (3). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.